Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1426 - 1426 of 1426

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 602 of 602

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1651 - 1675 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Guidance Document for the Costing of Health Care Resources in the Canadian Setting: Second Edition		Mar 30, 2016	Health Technology Review		MH0002-CP0009
Sofosbuvir/ velpatasvir	cdr_SR0486_TBC.pdf SR0486_complete_Epclusa-Oct-28-16.pdf SR0486_Epclusa_CL_Report.pdf SR0486_Epclusa_PE_Report.pdf SR0486_Epclusa_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0486-000
Vedolizumab	cdr_SR0487_Entyvio.pdf SR0487_complete_Entyvio-Oct-31-16.pdf SR0487_Entyvio_CL_Report.pdf SR0487_Entyvio_PE_Report.pdf SR0487_Entyvio_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0487-000
Jakavi for Polycythemia Vera - Details	pcodr_profund_ruxolitinib_jakavi_pv.pdf pcodr_ruxolitinib_jakavi_pv_fn_rec.pdf pcodr_ruxolitinib_jakavi_pv_fn_cgr.pdf pcodr_ruxolitinib_jakavi_pv_fn_egr.pdf pcodr_ruxolitinib_jakavi_pv_in_rec.pdf pcodr_ruxolitinib_jakavi_pv_pagfdk.pdf pcodr_ruxolitinib_jakavi_pv_fdk_novartis.pdf pcodr_ruxolitinib_jakavi_pv_ptfdk_mpn.pdf pcodr_ruxolitinib_jakavi_pv_coi_mpn.pdf	Mar 18, 2016	Reimbursement Review	Complete	PC0065-000
Brivaracetam	cdr_SR0484_Brivlera.pdf SR0484_Brivlera_CL_Report.pdf SR0484_Brivlera_PE_Report.pdf sr0484_complete_brivlera_jan-27-17.pdf	Mar 17, 2016	Reimbursement Review	Complete	SR0484-000
Infliximab	cdr_SE0483_Inflectra.pdf SE0483_IBD_Inflectra-Oct-28-16.pdf SE0483_Inflectra_PI_Submission_Consolidated.pdf SE0483_Inflectra_SEB_Report.pdf	Mar 11, 2016	Reimbursement Review	Complete	SE0483-000
Etanercept	cdr_SE0485_TBC.pdf SE0485_complete_Brenzys-Oct-27-16.pdf se0485_brenzys_pi.pdf se0485_brenzys_seb_report.pdf	Mar 9, 2016	Reimbursement Review	Complete	SE0485-000
Ixekizumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0481_TBC.pdf SR0481_complete_Taltz-oct-27-16.pdf SR0481_Taltz_PI_Submissions.pdf SR0481_Taltz_CL_Report_e.pdf SR0481_Taltz_PE_Report_e.pdf	Feb 17, 2016	Reimbursement Review	Complete	SR0481-000
Selexipag	cdr_SR0482_Uptravi.pdf SR0482_complete_Uptravi-Oct-28-16.pdf SR0482_Uptravi_PI_Submissions.pdf SR0482_Uptravi_CL_Report_e.pdf SR0482_Uptravi_PE_Report.pdf	Feb 16, 2016	Reimbursement Review	Complete	SR0482-000
Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives	ES0300_Rare_Disease_Drugs_e.pdf	Feb 11, 2016	Health Technology Review		ES0300-000
Emtricitabine/tenofovir disoproxil fumarate	cdr_SR0479_Truvada.pdf SR0479_complete_Truvada_Aug-26-16.pdf SR0479_Truvada_CL_Report.pdf SR0479_Truvada_PE_Report.pdf SR0479_Truvada_PI_Submissions.pdf	Feb 4, 2016	Reimbursement Review	Complete	SR0479-000
Apremilast	cdr_SR0478_Otezla_Resub.pdf SR0478_complete_Otezla-Oct-28-16.pdf SR0478_Otezla_PI_Submissions.pdf SR0478_Otezla_CL_Report_e.pdf SR0478_Otezla_PE_Report_e.pdf	Jan 29, 2016	Reimbursement Review	Complete	SR0478-000
Secukinumab	cdr_SR0475_Cosentyx_AS.pdf SR0475_complete_Cosentyx_AS_Aug-25-16.pdf SR0475_CosentyxAS_CL_Report.pdf SR0475_CosentyxAS_PE_Report.pdf SR0475_CosentyxAS_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0475-000
Secukinumab	cdr_SR0476_Cosentyx_PsA.pdf SR0476_complete_Cosentyx_PsA_Aug-25-16.pdf SR0476_CosentyxPsA_CL_Report.pdf SR0476_CosentyxPsA_PE_Report.pdf SR0476_CosentyxPsA_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0476-000
Mifepristone and misoprostol	cdr_SR0473_Mifegymiso.pdf	Jan 18, 2016	Reimbursement Review	Withdrawn	SR0473 -000
ombitasvir/paritaprevir/ritonavir and dasabuvir	cdr_SF0466_Holkira_Pak.pdf SF0466_complete_Holkira_Pak_May-25-16.pdf SF0466_HolkiraPak_RfA_Review_Report.pdf SF0466_HolkiraPak_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0466-000
daclatasvir	cdr_SF0467_Daklinza.pdf SF0467_complete_Daklinza_May_25-16.pdf SF0467_Daklinza_RfA_Review_Report.pdf SF0467_Daklinza_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0467-000
sofosbuvir	cdr_SF0464_Sovaldi.pdf SF0464_complete_Sovaldi-May_19_16.pdf SF0464_Sovaldi_RfA_Review_Report.pdf SF0464_Sovaldi_RFA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0464-000
Sapropterin dihydrochloride	cdr_SR0472_Kuvan.pdf SR0472_complete_Kuvan-Oct-28-16.pdf SR0472_Kuvan_PI_Submissions.pdf SR0472_Kuvan_CL_Report_e.pdf SR0472_Kuvan_PE_Report_e.pdf	Jan 4, 2016	Reimbursement Review	Complete	SR0472-000
Vectibix for mCRC – Details	pcodr_provfund_panitumumab_vectibix_mcrc.pdf pcodr_panitumumab_vectibix_mcrc_fn_rec.pdf pcodr_panitumumab_vectibix_mcrc_fn_cgr.pdf pcodr_panitumumab_vectibix_mcrc_fn_egr.pdf pcodr_panitumumab_vectibix_mcrc_in_rec.pdf pcodr_panitumumab_vectibix_mcrc_pagfdk.pdf pcodr_panitumumab_vectibix_mcrc_fdk_amgen.pdf pcodr_panitumumab_vectibix_mcrc_coi_ccac.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0060-000
Revlimid for Newly Diagnosed MM – Details	pcodr_provfund_lenalidomide_revlimid_nd-mm.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_cgr.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_egr.pdf pcodr_lenalidomide_revlimid_mm_in_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_pagfdk.pdf pcodr_lenalidomide_revlimid_nd-mm_fdk_celgene.pdf pcodr_lenalidomide_revlimid_nd-mm_coi_mc.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0061-000
Zykadia for Metastatic Non-Small Cell Lung Cancer - Details	pcodr_provfund_ceritinib_zykadia_nsclc.pdf pcodr_ceritinib_zykadia_nsclc_fn_rec.pdf pcodr_ceritinib_zykadia_nsclc_fn_cgr.pdf pcodr_ceritinib_zykadia_nsclc_fn_egr.pdf pcodr_ceritinib_zykadia_nsclc_in_rec.pdf pcodr_ceritinib_zykadia_nsclc_pagfdk.pdf pcodr_ceritinib_zykadia_nsclc_fdk_novartis.pdf pcodr_ceritinib_zykadia_nsclc_ptfdk_lcc.pdf pcodr_ceritinib_zykadia_nsclc_coi_lcc.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0062-000
Alirocumab	cdr_SR0469_Praluent.pdf SR0469_complete_Praluent_Jul-20-16.pdf SR0469_Praluent_CL_Report.pdf SR0469_Praluent_PE_Report.pdf SR0469_Praluent_PI_Submissions.pdf	Dec 7, 2015	Reimbursement Review	Complete	SR0469-000
Keytruda for Metastatic Melanoma – Details	pcodr_provfund_pembrolizumab_keytruda_mm.pdf pcodr_pembrolizumab_keytruda_mm_fn_rec.pdf pcodr_pembrolizumab_keytruda_mm_fn_cgr.pdf pcodr_pembrolizumab_keytruda_mm_fn_egr.pdf pcodr_pembrolizumab_keytruda_mm_in_rec.pdf pcodr_pembrolizumab_keytruda_mm_pagfdk.pdf pcodr_pembrolizumab_keytruda_mm_fdk-merck.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_sysf.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_sysf.pdf pcodr_pembrolizumab_keytruda_mm_coi_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_cspa.pdf	Dec 1, 2015	Reimbursement Review	Complete	PC0058-000
Canakinumab	cdr_SR0463_Ilaris.pdf SR0463_Ilaris_sJIA_CL_Report.pdf SR0463_Ilaris_sJIA_PE_Report.pdf SR0463_complete_Ilaris_sJIA_June_21_16_e.pdf SR0463_Ilaris_SJIA_PI_Submissions.pdf	Nov 24, 2015	Reimbursement Review	Complete	SR0463-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81